Holen Sie sich die Stockscreener-App
15.60
0.57%
-0.09
Schlusskurs vom Vortag:
$15.69
Offen:
$15.58
24-Stunden-Volumen:
434.81K
Relative Volume:
0.84
Marktkapitalisierung:
$5.52B
Einnahmen:
$4.89B
Nettoeinkommen (Verlust:
$-263.00M
KGV:
-20.17
EPS:
-0.7734
Netto-Cashflow:
$-167.84M
1W Leistung:
+0.32%
1M Leistung:
+3.11%
6M Leistung:
+35.06%
1J Leistung:
-20.29%
1-Tages-Spanne:
$15.24
$15.87
1-Wochen-Bereich:
$15.24
$16.81
52-Wochen-Spanne:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Firmenname
Bausch Lomb Corp
Sektor
Telefon
908-541-5456
Adresse
520 APPLEWOOD CRESCENT, VAUGHAN
Vergleichen Sie BLCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.60 | 5.56B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | Goldman | Neutral |
| 2025-05-02 | Bestätigt | H.C. Wainwright | Buy |
| 2025-03-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Eingeleitet | Raymond James | Outperform |
| 2024-05-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Eingeleitet | Stifel | Hold |
| 2023-10-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-06-24 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-06 | Eingeleitet | Citigroup | Buy |
| 2022-05-31 | Eingeleitet | Deutsche Bank | Hold |
| 2022-05-31 | Eingeleitet | Goldman | Neutral |
| 2022-05-31 | Eingeleitet | Guggenheim | Buy |
| 2022-05-31 | Eingeleitet | JP Morgan | Neutral |
| 2022-05-31 | Eingeleitet | Jefferies | Buy |
| 2022-05-31 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-05-11 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic valueMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
Cautious Hold Rating on Bausch + Lomb: Awaiting Catalysts for Stock Valuation Boost - TipRanks
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $13 to $19 - 富途牛牛
RBC Raises Price Target on Bausch + Lomb to $19 From $17, Keeps Outperform Rating - MarketScreener
Needham maintains Hold rating on Bausch & Lomb stock amid pipeline potential - Investing.com UK
Bausch & Lomb stock price target raised to $19 by RBC on margin outlook - Investing.com UK
Jefferies raises Bausch & Lomb stock price target to $20 on strong growth outlook - Investing.com UK
Can Bausch + Lomb Corporation (S2L) stock sustain double digit ROE2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Can Bausch + Lomb Corporation stock resist sector downturns2025 Short Interest & Real-Time Volume Spike Alerts - newser.com
Using data models to predict Bausch + Lomb Corporation stock movementMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Earnings visualization tools for Bausch + Lomb CorporationForecast Cut & AI Based Buy and Sell Signals - newser.com
Why Bausch + Lomb Corporation stock could see breakout soonMarket Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Bausch + Lomb Sets Ambitious Growth Targets At Investor Day - Finimize
Short interest data insights for Bausch + Lomb CorporationJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Bausch + Lomb Brief: Will Unveil Plans to Achieve "Above-market revenue growth and meaningful margin expansion" - MarketScreener
Bausch + Lomb Brief: Said To Highlight Company "Transformation And Growth Strategy" At Investor Day Today - MarketScreener
Bausch + Lomb sets 5-7% revenue growth target through 2028 By Investing.com - Investing.com South Africa
Bausch + Lomb Unveils Strategic Growth Plan at Investor Day - TipRanks
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day - The Joplin Globe
Bausch + Lomb (NYSE: BLCO) projects $7B pipeline peak sales, sets 5–7% revenue CAGR - Stock Titan
How strong is Bausch + Lomb Corporation stock revenue growthJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
New Eye Tech Is Booming For Alcon, Stock Soars - Benzinga
(BLCO) Trading Advice (BLCO:CA) - news.stocktradersdaily.com
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsInsider Selling & Verified Entry Point Signals - newser.com
What is the fair value estimate for Bausch + Lomb Corporation (S2L) stock in 20252025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
What margin trends mean for Bausch + Lomb Corporation stockCPI Data & Weekly Breakout Watchlists - newser.com
Real time breakdown of Bausch + Lomb Corporation stock performance2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Stocks in play: Bausch + Lomb Corporation - The Globe and Mail
Bausch + Lomb (NYSE: BLCO) ONE by ONE Recycling totals 691,180 lbs, 114,037,136 units - Stock Titan
Medical Devices & SuppliesSpecialty Stocks Q3 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers - Yahoo Finance
Bausch + Lomb Corporation’s Growth Surge: Can New Contact Lens Tech Grab A Larger Chunk Of The Market? - Smartkarma
(BLCO) Strategic Market Analysis (BLCO:CA) - news.stocktradersdaily.com
Will Pharmaceuticals Division Momentum and Updated Outlook Shift Bausch + Lomb's (BLCO) Investment Narrative? - Yahoo Finance
Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):